Form 4: GE HealthCare Officer Boosts Stake with Equity Awards
Insider Transaction Report
GE HealthCare's Chief Accounting Officer, George A. Newcomb, increased his beneficial ownership through new restricted stock unit and employee stock option awards.
Summary
- George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc. (GEHC), acquired 1,309 shares of common stock in the form of restricted stock units (RSUs) on March 2, 2026.
- These RSUs represent the right to receive one share of GE HealthCare common stock each, with vesting scheduled as 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
- Newcomb also acquired 3,443 employee stock options on March 2, 2026, with an exercise price of $80.16 per share and an expiration date of March 2, 2036.
- The employee stock options will become exercisable on the same schedule as the RSUs: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
- Following these transactions, Newcomb beneficially owns 10,627 shares of common stock directly and 12 shares indirectly through a family member, in addition to the 3,443 employee stock options.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal. Insider buying, particularly by a key financial officer, suggests internal confidence in the company's prospects, which can be reassuring for investors.
Positives
- The acquisition of restricted stock units and employee stock options by a Chief Accounting Officer signals confidence in the company's future performance.
- These equity awards align the executive's financial interests directly with those of shareholders, incentivizing long-term value creation.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that executive equity awards, such as restricted stock units and stock options, are standard components of compensation packages across the healthcare technology industry. These awards are designed to attract and retain top talent while motivating executives to achieve long-term strategic goals that benefit shareholders.
Comparison to Industry Standards
- The structure of these equity awards, with multi-year vesting schedules, is consistent with common practices in the healthcare technology sector, similar to companies like Siemens Healthineers or Philips, which use similar long-term incentive plans to align executive interests with company performance.
- The grant of both RSUs and stock options provides a balanced incentive, offering both direct equity ownership and potential upside leverage, a strategy widely adopted by leading global technology and healthcare firms.
Stakeholder Impact
- Shareholders: The increased equity ownership by a key executive aligns management's interests with shareholder value creation, potentially fostering greater confidence.
- Employees: Executive compensation structures can influence overall company culture and compensation strategies, though direct impact on general employees is not detailed here.
Next Steps
- The restricted stock units will vest in three tranches on September 2, 2027, September 2, 2028, and September 2, 2029.
- The employee stock options will become exercisable in three tranches on September 2, 2027, September 2, 2028, and September 2, 2029.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of transaction for acquisition of restricted stock units and employee stock options. |
| 09/02/2027 | First vesting date for 33% of restricted stock units and exercisability date for 33% of employee stock options. |
| 09/02/2028 | Second vesting date for 33% of restricted stock units and exercisability date for 33% of employee stock options. |
| 09/02/2029 | Final vesting date for 34% of restricted stock units and exercisability date for 34% of employee stock options. |
| 03/02/2036 | Expiration date for employee stock options. |
| 03/04/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe acquisition of equity awards by a Chief Accounting Officer is generally a positive indicator, suggesting management's belief in the company's future. While not a direct 'buy' signal on its own, it reinforces a 'hold' recommendation for existing investors and provides a favorable data point for those considering an investment, as it aligns executive incentives with long-term shareholder value.
Keywords
GEHC, Insider Transaction, Executive Compensation, Restricted Stock Units, Employee Stock Options, Beneficial Ownership, Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.